News Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Continue Reading Previous New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral ClearanceNext XORTX Announces Participation at Upcoming Investor Conferences Related Stories News RadarFirst Unveils Radar AI Risk™, The Breakthrough Product Powering Next-Gen AI Compliance News The Elon Code Releases 2025 Transparency Update on Digital Cognitive Optimization News EXL announces availability of EXL Code Harbor™ and EXL Smart Agent Assist™ in the new AWS Marketplace AI Agents and Tools category News ASAPP’s GenerativeAgent Platform is Now Available in the New AWS Marketplace AI Agents and Tools Storefront News ARTICUL8 announces availability of LLM-IQ Evaluator and Network Topology Agents in the new AWS Marketplace AI Agents and Tools category News CloudBees announces the availability of the CloudBees MCP Server, the latest innovation behind CloudBees Unify, in the new AWS Marketplace AI Agents and Tools category
